The global single-use bioprocessing consumables market, valued at USD 8.1 billion in 2025, is projected to reach USD 8.9 billion in 2026 and USD 21.4 billion by 2035, representing a CAGR of 10.2% during the forecast period from 2026 to 2035. Recent capacity expansions demonstrate the growing commercial importance of the category. In June 2025, Sartorius expanded its Aubagne facility in France, nearly doubling its cleanroom space to approximately 9,000 m² and increasing capacity for single-use b...

The global single-use chromatography systems market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.0 billion in 2026 and USD 6.3 billion by 2035, representing a CAGR of 13.7% during the forecast period from 2026 to 2035. The growing scale of biologics manufacturing is increasing demand for advanced downstream purification infrastructure. In 2026, Aurobindo Pharma’s subsidiary TheraNym announced plans to invest USD 150–175 million in a new biologic drug substance facility for...

The global single-use bioprocessing equipment market, valued at USD 4.2 billion in 2025, is projected to reach USD 4.5 billion in 2026 and USD 9.5 billion by 2035, representing a CAGR of 8.7% during the forecast period from 2026 to 2035. Each biologic entering clinical or commercial production requires cell-culture, filtration, fluid-transfer and storage infrastructure. In 2025, the European Medicines Agency recommended 104 medicines for authorization, including 38 products with new active subst...

The global organs-on-chips market, valued at USD 100 million in 2025, is projected to reach USD 129 million in 2026 and USD 944 million by 2035, representing a CAGR of 24.8% during the forecast period 2026-2035. In terms of geographical regions, North America currently holds the highest share, accounting for ~45% of the overall market. In May 2026, Critical Path Institute launched the NAMs Developer Coalition, bringing together developers such as CN Bio, Curi Bio, Emulate, and InSphero to advanc...

The global rapid sterility testing for cell and gene therapies market, valued at USD 0.15 billion in 2025, is projected to reach USD 0.18 billion in 2026 and USD 0.80 billion by 2035, representing a CAGR of 18.0% during the forecast period from 2026 to 2035. The expanding clinical pipeline of advanced therapies has increased the demand for quality control methods that can deliver ultra-fast results. There is a prominent industry shift toward molecular diagnostics that utilize genetic targeting t...

The global automated rapid microbiology testing platforms market, valued at USD 48.7 million in 2025, is projected to reach USD 51.7 million in 2026 and USD 108.7 million by 2035, representing a CAGR of 8.6% during the forecast period 2026 to 2035. In terms of type of modality, biologics accounts for the highest share (over 60%) of the current market. With respect to type of offering, consumables dominate the current market.

The global mini bioreactors market, valued at USD 1.5 billion in 2025, is projected to reach USD 1.7 billion in 2026 and USD 4.0 billion by 2035, representing a CAGR of 10.4% during the forecast period 2026 to 2035. In terms of capacity of bioreactor, the 50 mL-250 mL segment holds the highest share of the current market. Based on the type of cell culture, the mammalian culture segment holds the largest share (close to 50%) of the current market.

The small scale bioreactors market is estimated to grow from USD 2,479 million in 2025 to reach USD 2,739 million in 2026 and USD 5,796 million by 2035, representing a CAGR of 8.68% during the forecast period 2026 to 2035. In 2025, the batch / fed batch mode of operation dominated the market and is estimated to hold 90% of the overall revenue share by 2035. Fed batch bioreactors provide controlled nutrient environment, preventing accumulation of inhibitory byproducts that can limit cell growth....

The global single use downstream bioprocessing market, valued at USD 3.78 billion in 2025, is projected to reach USD 4.21 billion in 2026 and USD 12.15 billion by 2035, with a CAGR of 12.5% during the forecast period 2026 to 2035. With respect to the scale of operation, commercial scale currently holds around 80% of the market share. This single use downstream bioprocessing market trends is driven by the transition of drug candidates from clinical to commercial stages, which demands high-volume...

The global rapid microbiology testing solutions market, valued at USD 560 million in 2025, is projected to reach USD 603 million in 2026 and USD 1,463 million by 2035, representing a 10.3% CAGR during the forecast period 2026 to 2035. In 2035, North America is likely to have high rapid microbiology testing solutions market size, capturing around 40% of the overall market share. This dominance is attributed to the presence of a well-established pharmaceutical manufacturing base, early adoption of...

The global nucleic acid isolation and purification market size, valued at USD 5.41 billion in 2025, is projected to reach USD 5.75 billion in 2026 and USD 10.52 billion by 2035, representing a CAGR of 6.9% during the forecast period 2026 to 2035. The global market for nucleic acid isolation and purification products is rapidly growing, driven by the widespread adoption of next generation sequencing technologies, increasing interest in molecular biology and growing R&D investments for discovery a...

The global plasma fractionation market valued at $ 5.3 billion in 2025, is project to reach $ 5.8 billion in 2026 and $ 12.7 billion by 2035, representing a higher CAGR of 9.1% during the forecast period 2026 to 2035. In terms of type of company, the in-house manufacturers’ segment holds the highest share of the market.In terms of scale of operation, the commercial segment dominates the global market. Based on the type of plasma-derived therapeutic products manufactured, immunoglobulins segme...

The global buffer preparation market, valued at USD 8.48 billion in 2025, is projected to reach USD 9.18 billion in 2026 and USD 17.96 billion by 2035, with a 7.7% CAGR during the forecast period 2026 to 2035. n January 2025, Medix Biochemica acquired CANDOR Bioscience to strengthen its portfolio of critical raw materials for the in vitro diagnostics (IVD) industry. North America is likely to capture the majority share (~40%) in the overall market in 2025, and this trend is unlikely to change in...

The phosphoramidite market, valued at USD 1.0 billion in 2025, is projected to reach USD 1.1 billion in 2026 and USD 2.7 billion by 2035, with a 10.4% CAGR during the forecast period 2026 to 2035. In August 2025, the 4th Annual Oligonucleotide Analytical Development and CMC Summit is likely to be held with an aim to exchange insights on optimized analytical approaches to ensure high-quality oligonucleotide synthesis. In April 2025, Integrated DNA Technologies partnered with Elegen to offer the...

The continuous manufacturing market valued at USD 2,599 million in 2025, is project to reach USD 2,847 million in 2026 and USD 4,193 million by 2035, representing a CAGR of 4.4% during the forecast period 2026 to 2035. This continuous process minimizes downtime and maximizes equipment utilization, leading to higher efficiency and productivity, reduced unit costs (around 40-50%), and expediated drug commercialization. Amongst the publicly revealed partnerships and collaborations in the continuous...

The global PFAS testing market is estimated to grow from USD 249.1 million in 2025 to reach USD 279.1 million in 2026 and USD 1,209.5 million by 2040, representing a CAGR of 11% during the forecast period 2026 to 2040. In January 2025, SGS acquired RTI Laboratories with the aim to expand their PFAS lab testing capabilities in North American region. In February 2025, TUV Rheinland announced the expansion of its PFAS testing capabilities by upgrading the testing services for PFAS analytes in plast...

The global sustainable packaging market, valued at USD 10.29 billion in 2025, is projected to reach USD 10.95 billion in 2026 and USD 19.19 billion by 2035, with a 6.4% CAGR during the forecast period 2026 to 2035. In June 2025, Mondi has entered into a collaboration with Saga Nutrition in order to create a recyclable packaging solution for the latter company’s dry pet food range. Further, it is worth highlighting that the sustainable packaging market in Latin America is expected to grow a...

The click chemistry and bioorthogonal chemistry market, valued at USD 1.04 billion in 2025, is projected to reach USD 1.14 billion in 2026 and USD 3.65 billion by 2040, with a 8.7% CAGR during the forecast period 2026 to 2040. In December 2024, Veraxa Biotech signed a research and development agreement with Navigo Proteins for the development of radiopharmaceuticals intended for the treatment of oncological disorders. In January 2025, Synaffix out-licensed their GlycoConnect technology (utilizin...

The precision farming market is estimated to grow from USD 10.4 billion in 2024 to reach USD 11.2 billion in 2025 and USD 27.3 billion by 2035, representing a higher CAGR of 9.3% during the forecast period.In May 2025, HyFarm announced a partnership with Fyllo for incorporating precision farming in the cultivation of Potato, using the latter’s precision technology. In April 2025, Topcon Agriculture launched a solution named Value Line Steering to revolutionize agriculture and make precision fa...

The chromatography instrumentation market is estimated to grow from USD 7.9 billion in 2024 to reach USD 8.3 billion in 2025 and USD 14.1 billion by 2035, representing a higher CAGR of 5.4% during the forecast period. The liquid chromatography instruments segment led the market, capturing the largest revenue share of more than 50.0% in 2025. Further, this segment is likely to grow at a CAGR of 5.9% over the forecast period.